Merz Therapeutics
NC - Raleigh
BiotechnologyFocus: Small Molecules
Merz Therapeutics is a life sciences company focused on Small Molecules.
NeurologyMetabolic DiseasesCardiovascularInfectious Diseases
Open Jobs
0
Products & Portfolio (4)
1 discontinued product not shown
AMPYRA
dalfampridine
LOE Approaching
ORAL · TABLET, EXTENDED RELEASE
Potassium Channel Antagonists
walking in adult patients with multiple sclerosis (MS)multiple sclerosis
2010
30
CUVPOSA
glycopyrrolate
LOE Approaching
ORAL · SOLUTION
tissues, including salivary glands. Glycopyrrolate indirectly reduces the rate of salivation by preventing the stimulation of these receptors.
chronic severe drooling in patients aged 3-16 years with neurologic conditions associated with problem drooling (e
2010
30
INBRIJA
levodopa
Peak
INHALATION · POWDER
Levodopa, the metabolic precursor of dopamine, crosses the blood-brain barrier and presumably is converted to dopamine in the brain. This is thought to be the mechanism whereby levodopa relieves symptoms of Parkinson's disease.
2018
0
Xeomin
incobotulinumtoxina
LOE Approaching
INJECTION · INJECTABLE
Acetylcholine Release Inhibitors
2010
30
Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 5 approved products
Top TAs: Neurology, Cardiovascular, Metabolic Diseases
Portfolio Health
Peak1 (20%)
LOE Approaching3 (60%)
Post-LOE1 (20%)
5 total products
Therapeutic Area Focus
Marketed
Pipeline
Hiring Trend
Stable
0
Open Roles
+0
Added
-0
Filled/Removed
Based on last 3 crawl cycles